These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34560539)

  • 41. Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis.
    Zhang YB; Liu SJ; Hu ZD; Zhou JX; Wang YZ; Fang B; Wong KW; Xia F
    Cancer Immunol Immunother; 2020 Dec; 69(12):2665-2671. PubMed ID: 32761425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
    Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
    BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Microbiota of Human Lung of Pulmonary Tuberculosis and the Alteration Caused by Anti-tuberculosis Drugs.
    Zhang M; Shen L; Zhou X; Chen H
    Curr Microbiol; 2022 Sep; 79(11):321. PubMed ID: 36121489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct lung microbial community states in patients with pulmonary tuberculosis.
    Hu Y; Kang Y; Liu X; Cheng M; Dong J; Sun L; Zhu Y; Ren X; Yang Q; Chen X; Jin Q; Yang F
    Sci China Life Sci; 2020 Oct; 63(10):1522-1533. PubMed ID: 32303963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases.
    Xu C; Hao M; Zai X; Song J; Huang Y; Gui S; Chen J
    Arch Microbiol; 2024 Feb; 206(3):107. PubMed ID: 38368569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The gut microbiota mediates protective immunity against tuberculosis
    Yang F; Yang Y; Chen L; Zhang Z; Liu L; Zhang C; Mai Q; Chen Y; Chen Z; Lin T; Chen L; Guo H; Zhou L; Shen H; Chen X; Liu L; Zhang G; Liao H; Zeng L; Zeng G
    Gut Microbes; 2022; 14(1):2029997. PubMed ID: 35343370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathology of TB/COVID-19 Co-Infection: The phantom menace.
    Mousquer GT; Peres A; Fiegenbaum M
    Tuberculosis (Edinb); 2021 Jan; 126():102020. PubMed ID: 33246269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A human xenobiotic nuclear receptor contributes to nonresponsiveness of
    Bhagyaraj E; Tiwari D; Ahuja N; Nanduri R; Saini A; Kalra R; Kumar S; Janmeja AK; Gupta P
    J Biol Chem; 2018 Mar; 293(10):3747-3757. PubMed ID: 29358328
    [No Abstract]   [Full Text] [Related]  

  • 50. A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.
    Kondratieva TK; Kapina MA; Rubakova EI; Kondratieva EV; Nikonenko BV; Majorov KB; Dyatlov AV; Linge IA; Apt AS
    Tuberculosis (Edinb); 2018 Dec; 113():130-138. PubMed ID: 30514495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis.
    Lin D; Wang X; Li Y; Wang W; Li Y; Yu X; Lin B; Chen Y; Lei C; Zhang X; Zhang X; Huang J; Lin B; Yang W; Zhou J; Zeng J; Liu X
    Int J Med Sci; 2021; 18(9):1935-1945. PubMed ID: 33850462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis.
    Khan N; Mendonca L; Dhariwal A; Fontes G; Menzies D; Xia J; Divangahi M; King IL
    Mucosal Immunol; 2019 May; 12(3):772-783. PubMed ID: 30783183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.
    Schwander S; Dheda K
    Am J Respir Crit Care Med; 2011 Mar; 183(6):696-707. PubMed ID: 21075901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Koumiss promotes Mycobacterium bovis infection by disturbing intestinal flora and inhibiting endoplasmic reticulum stress.
    Wang H; Hussain T; Yao J; Li J; Sabir N; Liao Y; Liang Z; Wang Y; Liu Y; Zhao D; Zhou X
    FASEB J; 2021 Sep; 35(9):e21777. PubMed ID: 34403519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks.
    Enaud R; Prevel R; Ciarlo E; Beaufils F; Wieërs G; Guery B; Delhaes L
    Front Cell Infect Microbiol; 2020; 10():9. PubMed ID: 32140452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A subset of CD1c
    Liu Y; Wang R; Jiang J; Cao Z; Zhai F; Sun W; Cheng X
    Tuberculosis (Edinb); 2018 Dec; 113():189-199. PubMed ID: 30514502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model.
    Rosa CP; Pereira JA; Cristina de Melo Santos N; Brancaglion GA; Silva EN; Tagliati CA; Novaes RD; Corsetti PP; de Almeida LA
    J Leukoc Biol; 2020 Jan; 107(1):95-104. PubMed ID: 31682032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved Mycobacterium tuberculosis clearance after the restoration of IFN-γ
    Kamboj D; Gupta P; Basil MV; Mohan A; Guleria R; Bhatnagar A; Mehta G; Kumar P; Saurabh A; Deepak R; Thakral D; Misra P; Tandon R; Gupta UD; Mitra DK
    Eur J Immunol; 2020 May; 50(5):736-747. PubMed ID: 32113187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.